New Paper Led by Chloe Gulliver

Published: 21 February 2024

Article published in Molecular Oncology

cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.

Chloe Gulliver, Tara Busiau, Ashleigh Byrne, Jane E. Findlay, Ralf Hoffmann, George S. Baillie

Link to Paper

Abstract Image

Summary

In this paper we report the existence of a novel cyclic AMP signalosome involving PDE4D7 and DHX9, which appears to play a fundamental role in prostate cancer progression. Use of a cell-permeable disruptor peptide to disrupt the interaction between PDE4D7 and DHX9 is capable of hindering cell growth, potentially representing a new therapeutic target for prostate cancer.

First published: 21 February 2024

<< December to February 2024


Related Links

Link to Article

Dr Chloe Gulliver

Prof George Baillie